AstraZeneca today named Pascal Soriot as the company’s Chief Executive Officer.
Soriot, a French national, joins AstraZeneca from Roche AG where he served as Chief Operating Officer of the company’s pharmaceutical divison for the past two years.
Here is what Leif Johansson, Chairman of AstraZeneca, had to say: “This is a key appointment at an important time for AstraZeneca and we are certain that Pascal’s leadership qualities combined with his strategic thinking and relevant experience make him the right person to drive the company to success over the coming years. I am confident that Pascal’s approach and his track record of delivering results in innovation-driven businesses will be valued by shareholders and employees alike.”
Soriot also formerly served as CEO of Genentech, where he was credited with leading the successful merger between the San Francisco-based biologics business and Roche. Pascal Soriot joined the pharmaceutical industry in 1986 and has worked in senior management roles in the US, Asia and Europe.
The full announcement can be found here.